Glenmark

Glenmark settles US lawsuit over Generic Zetia and Vytorin for $7 million

Glenmark shares surge 4% following positive Phase 1 trial results for ISB 2001

Ichnos Glenmark Innovation announces promising Phase 1 results for trispecific antibody ISB 2001 in relapsed multiple myeloma, showing 75% response rate

Glenmark Pharmaceutical reports 30.04% rise in net profits for Q3

Glenmark Pharma share price escalates post tentative USFDA nod for kidney cancer drug

Glenmark receives final approval for Tacrolimus capsules from FDA

Glenmark Pharmaceuticals has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Tacrolimus Capsules USP, the generic version of Prograf® Capsules, of Astellas Pharm US.

Glenmark denies claim of FabiFlu drug being overpriced

Glenmark in its letter on Monday clarified that the price of the drug was last week slashed by 27% to ₹75 per tablet, which along with it, brought the cost of an entire course of 122 tablets for two weeks down to ₹9,150.

COVID-19: Glenmark launches Coronavirus drug at ₹103 per tablet in India